These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6441235

  • 1. Cryoprecipitate and Factor VIII commercial concentrates: in vitro characteristics and in vivo compartmental analysis.
    Morfini M, Longo G, Matucci M, Vannini S, Messori A, Filimberti E, Duminuco M, Avanzi G, Rossi-Ferrini P.
    Ric Clin Lab; 1984; 14(4):681-91. PubMed ID: 6441235
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factor VIII procoagulant activity, factor VIII related antigen and von Willebrand factor in newborn cord blood.
    Fukui H, Takase T, Ikari H, Murakami Y, Okubo Y, Nakamura K.
    Br J Haematol; 1979 Aug; 42(4):637-46. PubMed ID: 314304
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S, Takahashi Y, Nishino M, Okubo Y, Fukui H.
    Thromb Haemost; 1981 Jun 30; 45(3):272-5. PubMed ID: 6792740
    [Abstract] [Full Text] [Related]

  • 12. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV, Griffin B, Pepper DS, Dickson AJ, McQuillan TA, Dickson IH, Foster PR.
    Thromb Haemost; 1981 Oct 30; 46(3):597-601. PubMed ID: 6797090
    [Abstract] [Full Text] [Related]

  • 13. Modification of factor VIII complex properties in patients with liver disease.
    Maisonneuve P, Sultan Y.
    J Clin Pathol; 1977 Mar 30; 30(3):221-7. PubMed ID: 300380
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasma.
    Amrani DL, Mosesson MW, Hoyer LW.
    Blood; 1982 Mar 30; 59(3):657-63. PubMed ID: 6800421
    [Abstract] [Full Text] [Related]

  • 16. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
    Allain JP, Croissant MP, Lerolle D, Houbouyan L, Zuzel M, Frommel D.
    Thromb Haemost; 1982 Oct 29; 48(2):142-5. PubMed ID: 6817443
    [Abstract] [Full Text] [Related]

  • 17. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H, Itoh M, Kobayashi I, Sakuragawa N, Shibata A.
    Tohoku J Exp Med; 1980 Oct 29; 132(2):133-40. PubMed ID: 6777902
    [Abstract] [Full Text] [Related]

  • 18. [Study of a therapeutic concentrate of factor VIII/vWf prepared in a closed system].
    Mazurier C, Maillard J, Parquet-Gernez A, Goudemand M.
    Rev Fr Transfus Immunohematol; 1982 Feb 29; 25(1):25-43. PubMed ID: 6803339
    [Abstract] [Full Text] [Related]

  • 19. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
    Winocour PD, Lopes-Virella M, Laimins M, Colwell JA.
    J Lab Clin Med; 1983 Nov 29; 102(5):795-804. PubMed ID: 6415193
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.